Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07488208 · ClinicalTrials.gov registry record · NA
Comparison of Two Contact Lens Designs
A NA study, sponsored by Southern College of Optometry.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07488208: Completed NA study, sponsored by Southern College of Optometry.
NCT07488208 is a NA study that has completed, run by Southern College of Optometry. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07488208, a NA study, has completed, sponsored by Southern College of Optometry.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The proposed study will address this gap by comparing the efficacy of two novel stenfilcon A contact lens designs in alleviating accommodative burden associated with digital device usage. The primary outcomes are measured with the following: * Computer vision syndrome questionnaire * Binocular logMar (H/Lo contrast) visual acuity at 6M and 40cm. * Binocular range of clear vision * Subjective assessment of accommodation * Objective assessment of accommodation Subjects will be randomly assigned to wear one contact lens design for 5 days. Then crossed over tot he opposing design after a three day washout period, and again asked to wear the lens for 5 days.
Primary Outcome
Computer vision syndrome questionnaire (CVS-Q) is a reliable and valid tool for measuring visual symptoms related to computer use in the workplace. It asks subjects to rate the frequency (never, occasionally, often) and intensity (moderate, intense) of 16 visual symptoms.
Interventions
- DEVICE Stenfilcon A contact lens designs with and without Digital Boost technology that incorporate a 0.3D add power into the lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-05-22 |
| Est. Completion | 2025-09-02 |
| Phase | NA |
What the finished NCT07488208 record still lists
NCT07488208 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Stenfilcon A contact lens designs with and without Digital Boost technology that incorporate a 0.3D add power into the lens is the first listed.
NCT07488208 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07488208 about?
NCT07488208 is a clinical study titled "Comparison of Two Contact Lens Designs". The proposed study will address this gap by comparing the efficacy of two novel stenfilcon A contact lens designs in alleviating accommodative burden associated with digital device usage. The primary outcomes are measured with the following: * Computer vision syndrome questionnaire * Binocular log...
What is the current status of trial NCT07488208?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2025-05-22. Estimated completion is 2025-09-02.
What interventions are being tested in trial NCT07488208?
The interventions under investigation include: Stenfilcon A contact lens designs with and without Digital Boost technology that incorporate a 0.3D add power into the lens (DEVICE).
Who is sponsoring clinical trial NCT07488208?
This trial is sponsored by Southern College of Optometry, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07488208's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI